NEW: CIBMTR Research IMPACT for patients with inborn errors of immunity from the Primary Immune Deficiency Treatment Consortium Read more: 🔗pubmed.ncbi.nlm.nih.gov/42242424/
CIBMTR
@cibmtr.bsky.social
Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy. Learn more at cibmtr.org.
Staying up to date is simple. Sort Study Summaries by date to see the latest findings and newly added studies. Explore what’s new: cibmtr.org/summaries
NEW: CIBMTR Research Comparison of fludarabine versus bendamustine as a lymphodepleting chemotherapy prior to CAR T for large cell lymphoma Read more: 🔗pubmed.ncbi.nlm.nih.gov/42341926/
CIBMTR and the MCW Division of Hematology and Oncology invite applications for a faculty position as a CIBMTR Senior Scientific Director. Learn more about and apply for this important position: mcw.wd503.myworkdayjobs.com/en-US/Extern...
Take a look—filter our Study Summaries by disease or condition. Quickly explore plain-language info on lymphoma, multiple myeloma, sickle cell disease, and more: cibmtr.org/summaries
🔬 What's new at CIBMTR? The August 2026 Newsletter is here! Explore research highlights from our working committees, updates on adoptive cellular therapies & gene therapy reporting, 2025 US Summary Slides, and a preview of #Tandem27. 📬 cibmtr.org/CIBMTR/About...
NEW: CIBMTR Research Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR analysis Read more: 🔗pubmed.ncbi.nlm.nih.gov/42364732/
It’s easy to explore our Study Summaries page. Browse by category and quickly find plain-language research summaries—in a clear, user-friendly format. Check it out: cibmtr.org/summaries
NEW: CIBMTR Research Quantile regression of the relationship between demographic factors and leukocyte telomere length, measured by Southern blot and qPCR Read more: 🔗pubmed.ncbi.nlm.nih.gov/41619133/
NEW: CIBMTR Research Recommendations for HLA genotyping data standards and clinical laboratory staffing considerations Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42007733/
Need more transplant resources? Our Study Summaries page now links to clinical trial summaries and education tools to support every step of the journey. Explore more ➡️ cibmtr.org/summaries
NEW: BMT CTN Research Antigen-specific T cell responses to SARS-CoV-2 vaccination after HCT or CAR T-cell therapy Read more: 🔗pubmed.ncbi.nlm.nih.gov/41941698/
NEW: CIBMTR Research Patients with MDS/MPN have higher rates of relapse following allogeneic HCT compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis Read more: 🔗pubmed.ncbi.nlm.nih.gov/42032308/
NEW: CIBMTR Research Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy Read more: 🔗pubmed.ncbi.nlm.nih.gov/42060959/
NEW: CIBMTR Research Factors associated with receipt of allogeneic HCT and NMDP donor search in older adults with AML Read more: 🔗pubmed.ncbi.nlm.nih.gov/42069181/
NEW: CIBMTR Research Donor source selection in HCT: Practices and perceptions across 50 U.S. transplant centers Read more: 🔗pubmed.ncbi.nlm.nih.gov/42086170/
NEW: CIBMTR Research Outcomes of HCT in patients with plasmablastic lymphoma Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42173253/
Guiding a patient through transplant prep? Our Study Summaries turn complex research into clear, easy‑to‑read explanations—helping patients stay informed and confident. Start exploring ➡️cibmtr.org/summaries
NOW AVAILABLE: 2025 CIBMTR Summary Slides. These slides provide an annual report on data submitted by US centers to CIBMTR, detailing practices and general survival outcomes following cellular therapies. Learn more: cibmtr.org/CIBMTR/Resou...
Children who donate blood or marrow need more support. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
Sibling donors reduce chances of graft-versus-host disease. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
Kids who have transplant may have fertility problems later. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
New tool predicts risk of long-term effects after transplant. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summ...
Want the newest transplant research at your fingertips? You can now sort our Study Summaries by date—making it simple to track recent findings and stay informed as new studies roll out. Take a look ➡️ cibmtr.org/summaries
🚨 New for 2026! 🚨 After #Tandem26, CIBMTR is proud to share the accepted Working Committee studies—advancing innovation in cellular therapy & transplantation. See the full list: 🔗 cibmtr.org/Files/2026-N... #CIBMTR #CellTherapy #BMT #Research
Trustworthy transplant research—now easier to find. Explore Study Summaries organized by disease and condition: lymphoma, multiple myeloma, sickle cell disease, and more. Start exploring ➡️cibmtr.org/summaries
Our study summaries page just got a major upgrade! Search by category, find what you need faster, and browse clear, plain‑language summaries. Explore the new layout ➡️ cibmtr.org/summaries
